A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

Clinical trial NCT06239116 · RECRUITING

Trial details

NCT number: NCT06239116
Sponsor: Rhythm Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hypothalamic Obesity Prader-Willi Syndrome PWS

Start date: 2024-03-05
Primary completion: 2027-11-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.